
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Venlafaxine Extended-Release (Effexor XR) is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder.
Medication Pearl of the Day: Venlafaxine Extended-Release (Effexor XR)
Indication: Venlafaxine Extended-Release (Effexor XR) is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder.
Insight:
Source: https://labeling.pfizer.com/showlabeling.aspx?ID=100






